Whole blood aggregation and coagulation in db/db and ob/ob mouse models of type 2 diabetes

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 2, 2008, Pages 124-134

  Henry, Melissa L ^a,d   Davidson, Lisa B ^b   Wilson, Jonathan E ^a   McKenna, Brenda K ^a   Scott, Sheree A ^a   McDonagh, Paul F ^b,c   Ritter, Leslie S ^a,b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF NORTHERN COLORADO   (United States)

Author keywords

CD61; db db mouse; ob ob mouse; Platelets; Thromboelastography; Whole blood aggregometry

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CD61 ANTIGEN; FUCOIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FLOW CYTOMETRY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD COAGULATION; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; MICE; MICE, OBESE; PLATELET AGGREGATION; THROMBELASTOGRAPHY; THROMBOPHILIA;

EID: 39149137482     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282f41e56     Document Type: Article

References (52)

1. Carr ME. Diabetes mellitus: a hypercoaguable state. J Diabetes Complications 2001; 15:44-54.
2. Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T, et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995; 116:235-240.
3. McDonagh PF, Hokama JY, Gale SC, Logan JJ, Davis-Gorman G, Goldman S, et al. Chronic expression of platelet adhesion proteins is associated with severe heart disease in type 2 diabetic patients. Chronic platelet activation in diabetic heart patients. J Diabetes Complications 2003; 17:269-278.
4. Koga H, Sugiyama S, Kugiyama K, Fukushima H, Watanabe K, Sakamoto T, et al. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J 2006; 27:817-823.
5. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JWA, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002; 106:2442-2447.
6. Ferreira IA, Mocking AIM, Feijge MAH, Gorter G, van Haeften TW, Heemskerk JWM, et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2006; 26:417-422.
7. 2+ mobilization and aggregation in platelets from type 2 diabetic patients. Biochem Biophys Res Commun 2005; 333:794-802.
8. Coppola G, Corrando E, Muratori L, Tantillo R, Vitale G, Lo Coco L, Novo S. Increased levels of c-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Cardiol 2006; 106:16-20.
9. Coca M, Cucuianu M, Hancu N. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting factors VII and VIII, fibrinogen, and von Willebrand factor. Rom J Int Med 2005; 43:115-126.
10. Erem C, Hacihasanoglu A, Celik S, Ovali E, Ersoz HO, Ukinc K, et al. Coagulation and fibrinolysis parameters in type 2 diabetes patients with and without diabetic vascular complications. Med Princ Pract 2005; 14:22-30.
11. Ludwig S, Dharmalingham S, Erickson-Nesmith S, Ren S, Zhu F, Ma GM, et al. Impact of simvastatin on hemostatic and fibrinolytic regulators in type 2 diabetes mellitus. Diabetes Res Clin Pract 2005; 70:110-118.
12. Dunn EJ, Philippou H, Ariens RAS, Grant PJ. Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia 2006; 49:1071-1080.
13. Lee G-H, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379:632-635.
14. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
15. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9:294-298.
16. Coleman DL, Hummel KP. Studies with the mutation, diabetes, in the mouse. Diabetologia 1967; 3:238-248.
17. Dubac PU. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism 1976; 25:1567-1574.
18. Office of Laboratory Animal Welfare. Public health service policy on humane care and use of laboratory animals. NIH publication no. 80-23. Washington, DC: US Government Printing Office; 2002.
19. Brown BA. Routine hematology principles. In: Brown BA, editor. Hematology: principles and procedures, 3rd ed. Philadelphia, PA: Lea & Febiger; 1980. pp. 71-112.
20. Koplitz SL, Scott MA, Cohn LA. Effects of platelet clumping on platelet concentrations measured by use of impedence or buffy coat analysis in dogs. J Am Vet Med Assoc 2001; 219:1552-1556.
21. Goldenberg SJ, Veriabo NJ, Soslau G. A micromethod to measure platelet aggregation and ATP release by impedence. Thromb Res 2001; 103:57-61.
22. Bowbrick VA, Mikhailidis DP, Stansby G. Influence of platelet count and activity on thromboelastography parameters. Platelets 2003; 14:219-224.
23. Salooja N, Perry DJ. Thromboelastography. Blood Coagul Fibrinolysis 2001; 12:327-337.
24. DeKeyser FG, Pugh LC. Approaches to physiologic measurement: reliability and validity. In: Waltz C, Strickland O, Lenz E, editors. Measurement in nursing research. Philadelphia, PA: F.A. Davis; 1991. pp. 400-405.
25. Everds N. Chapter 17: hematology of the mouse. In: Hedrich HJ, Bullock G, editors. The laboratory mouse (handbook of experimental animals). London: Elselvier Academic Press; 2004. pp. 271-286.
26. Samad F, Pandey M, Bell PA, Loskutoff DJ. Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes. Mol Med 2000; 6:680-692.
27. Samad F, Pandey M, Loskutoff DJ. Regulation of tissue factor gene expression in obesity. Blood 2001; 98:3353-3358.
28. Rosenblum WI, El-Sabban F, Loria RM. Platelet aggregation in the cerebral and mesenteric microcirculation of mice with genetically determined diabetes. Diabetes 1981; 30:89-92.
29. Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108:1533-1540.
30. Elbatarny HS, Maurice DH. Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex. Am J Physiol Endocrinol Metab 2005; 289:E695-E702.
31. i increase via JAK2 and tyrosine kinases in a megakaryoblast cell line. Diabetes Res Clin Pract 2005; 70:209-216.
32. Giandomenico G, Dellas C, Czekay R-P, Koschnick S, Loskutoff DJ. The leptin receptor system of human platelets. J Thromb Haemost 2005; 3:1042-1049.
33. Corsonello A, Malara A, DeDomenico D, Perticone F, Valenti A, Buemi M, et al. Identifying pathways involved in leptin-dependent aggregation of human platelets. Int J Obes 2004; 28:979-984.
34. May JA, Heptinstall S. Effects of anticoagulants used during blood cell collection on human platelet function. In: Gibbons JM, Mahaut-Smith MP, editors. Methods and molecular biology, vol. 272: Platelets and megakaryocytes, Vol: 1: Functional assays. Totowa, NJ: Humana Press, Inc.; 2004. pp. 3-11.
35. Jarvis GE. Platelet aggregation in whole blood. Impedence and particle counting methods. In: Gibbons JM, Mahaut-Smith MP, editors. Methods and molecular biology, vol. 272: Platelets and megakaryocytes, Vol: 1: Functional assays. Totowa, NJ: Humana Press, Inc; 2004. pp. 77-87.
36. Vollmar B, Slotta JE, Nickels RM, Wenzel E, Menger MD. Comparative analysis of platelet isolation techniques for the in vivo study of the microcirculation. Microcirculation 2003; 10:143-152.
37. Walkowiak B, Kralisz U, Michalec L, Majewska E, Koziolkiewicz W, Liqocka A, et al. Comparison of platelet aggregability and p-selectin expression on platelets isolated by different methods. Thromb Res 2000; 99:495-502.
38. Paul W, Queen LR, Page CP, Ferro A. Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat. Br J Pharm 2007; 150:105-111.
39. Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Caroll RC. A novel modification of the thromboelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004; 143:301-309.
40. Jones SP, Girod WG, Granger DN, Palazzo AJ, Lefer DJ. Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart. Am J Physiol 1999; 277:H763-H769.
41. Golanski J, Pietrucha T, Baj Z, Gregor J, Watala C. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood - various anticoagulants are not equal. Thromb Res 1996; 83:199-216.
42. Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost 1999; 81:177-188.
43. Sobal M, Fish WR, Toma N, Luo S, Bird K, Mori K, et al. Heparin modulates integrin function in human platelets. J Vasc Surg 2001; 33:587-594.
44. Mehta SS, Silver RJ, Aaronson A, Abrahamson M, Goldfine AB. Comparison of aspirin resistance in type 1 versus type2 diabetes mellitus. Am J Cardiol 2006; 97:567-570.
45. Bertau O, Mulloy B. Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 2003; 13:29R-40R.
46. Trento F, Cattaneo F, Pescador R, Porta R, Ferro L. Antithrombin activity of an algal polysaccharide. Thromb Res 2001; 102:457-465.
47. Thorlacius H, Vollmer B, Seyfert UT, Vestweber D, Menger MD. The polysaccharide fucoidan inhibits microvascular thrombus formation independently from P- and L-selectin function in vivo. Eur J Clin Invest 2000; 30:804-810.
48. Davidson L, McDonagh P, Nolan P, Ritter L. Fucoidan is nearly as effective as aspirin in inhibiting platelet aggregation in whole blood [abstract]. FASEB J 2005; 19:629.3.
49. Awtry EH, Loscalzo J. Aspirin. Circulation 2000; 101:1206-1218.
50. Tamminen M, Lassila R, Westerbacka J, Vehkavaara S, Yki-Jarvinen H. Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects. Int J Obes 2006; 27:907-911.
51. 2) coordination mode. J Inorg Biochem 2001; 85:179-186.
52. Wyse BM, Dulin WE. The influence of age and dietary conditions on diabetes in the db mouse. Diabetologia 1970; 6:268-273.